Suchergebnisse - "Gentile, Ivan"

PubPharm (345)

11

Predicting de‐novo portal vein thrombosis after HCV eradication : A long‐term competing risk analysis in the ongoing PITER cohort

enthalten in: United European Gastroenterology Journal | 2024

von Kondili, L. | Zanetto, A. | Quaranta, M. | +33

12

Early combination with remdesivir, nirmatrelvir/ritonavir and sotrovimab for the treatment of COVID-19 in immunocompromised hosts

enthalten in: ResearchSquare.com | 2023

von Gentile, I. | Foggia, M. | Silvitelli, M. | +3

13

Optimizing COVID-19 treatment in immunocompromised patients : early combination therapy with remdesivir, nirmatrelvir/ritonavir and sotrovimab

enthalten in: Virology journal | 2023

von Gentile, I. | Foggia, M. | Silvitelli, M. | +3

14

Optimizing COVID-19 treatment in immunocompromised patients: early combination therapy with remdesivir, nirmatrelvir/ritonavir and sotrovimab

enthalten in: Virology journal | 2023

von Gentile, I. | Foggia, M. | Silvitelli, M. | +3

15

The MBL2 genotype relates to COVID-19 severity and may help to select the optimal therapy

enthalten in: Clinical chemistry and laboratory medicine | 2023

von Scialò, F. | Cernera, G. | Esposito, S. | +7

16

Prevalence of Pneumocystis jirovecii Colonization in Non-Critical Immunocompetent COVID-19 Patients : A Single-Center Prospective Study (JiroCOVID Study)

enthalten in: Microorganisms | 2023

von Buonomo, A. | Viceconte, G. | Fusco, L. | +5

17

Efficacy and Safety of Reparixin in Patients with Severe COVID-19 Pneumonia : A Phase 3, Randomized, Double-Blind Placebo-Controlled Study

enthalten in: Infectious diseases and therapy | 2023

von Piemonti, L. | Landoni, G. | Voza, A. | +31

18

Pre-exposure prophylaxis for COVID-19 with Tix-agevimab/Cilgavimab in kidney transplant recipients in the Kraken variant (XBB.1.5) era: A Single-center Experience

enthalten in: Preprints.org | 2023

von Pinchera, B. | Carrano, R. | Salemi, F. | +8

19

Efficacy and Safety of Reparixin in Patients with Severe COVID-19 Pneumonia: A Phase 3, Randomized, Double-Blind Placebo-Controlled Study

enthalten in: Infectious diseases and therapy | 2023

von Piemonti, L. | Landoni, G. | Voza, A. | +31

20

Outcome of patients with carbapenem-resistant Acinetobacter baumannii infections treated with cefiderocol : A multicenter observational study

enthalten in: Journal of infection and public health | 2023

von Calò, F. | Onorato, L. | De Luca, I. | +13